Jeffrey Reynolds

Jeff brings almost 35 years of professional experience, and a broad base of practical knowledge enabling him to drive for solutions in both the scientific and management arenas.

He has supported many phases of drug product development including early phase pre-IND to phase I/II/II clinicals, and life cycle management and post approval support. He has worked with small, medium, and large companies, including GlaxoSmithKline, Coty, Tergus Pharma, and KIK Custom Products; and is co-inventor on three patents and several patents pending. Jeff is recognized as an expert in quality by design as it pertains to formulation development and manufacturing; and his experience includes research and development of pharmaceutical dosage across a broad spectrum of therapeutic areas, including dermatology, aesthetics, GI, CNS, and URT.

Jeff received a B.S. in chemistry from Fairleigh Dickinson University and an MBA from American Intercontinental University. Jeff is a member of the AAPS, the SCC, and Delta Mu Delta and has served on the executive board for the aerosol products division of the HCPA.